Logo image of SCANA.OL

SCANA ASA (SCANA.OL) Stock Fundamental Analysis

Europe - OSL:SCANA - NO0003053308 - Common Stock

1.556 NOK
+0.03 (+2.1%)
Last: 11/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall SCANA gets a fundamental rating of 3 out of 10. We evaluated SCANA against 107 industry peers in the Machinery industry. While SCANA is still in line with the averages on profitability rating, there are concerns on its financial health. SCANA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SCANA had positive earnings in the past year.
SCANA had a positive operating cash flow in the past year.
SCANA had positive earnings in 4 of the past 5 years.
Each year in the past 5 years SCANA had a positive operating cash flow.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.43%, SCANA is doing worse than 78.50% of the companies in the same industry.
Looking at the Return On Equity, with a value of -8.91%, SCANA is doing worse than 78.50% of the companies in the same industry.
Industry RankSector Rank
ROA -3.43%
ROE -8.91%
ROIC N/A
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

In the last couple of years the Profit Margin of SCANA has grown nicely.
In the last couple of years the Operating Margin of SCANA has grown nicely.
With a decent Gross Margin value of 56.32%, SCANA is doing good in the industry, outperforming 75.70% of the companies in the same industry.
SCANA's Gross Margin has improved in the last couple of years.
SCANA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.32%
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1

2. Health

2.1 Basic Checks

SCANA does not have a ROIC to compare to the WACC, probably because it is not profitable.
SCANA has more shares outstanding than it did 1 year ago.
SCANA has more shares outstanding than it did 5 years ago.
SCANA has a better debt/assets ratio than last year.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

The Debt to FCF ratio of SCANA is 6.34, which is on the high side as it means it would take SCANA, 6.34 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 6.34, SCANA perfoms like the industry average, outperforming 47.66% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that SCANA is somewhat dependend on debt financing.
SCANA's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. SCANA is outperformed by 61.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 6.34
Altman-Z N/A
ROIC/WACCN/A
WACC8.26%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SCANA has a Current Ratio of 0.95. This is a bad value and indicates that SCANA is not financially healthy enough and could expect problems in meeting its short term obligations.
SCANA has a worse Current ratio (0.95) than 85.98% of its industry peers.
A Quick Ratio of 0.79 indicates that SCANA may have some problems paying its short term obligations.
SCANA has a Quick ratio of 0.79. This is in the lower half of the industry: SCANA underperforms 70.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.79
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

SCANA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -149.44%.
The Earnings Per Share has been growing by 21.20% on average over the past years. This is a very strong growth
The Revenue for SCANA has decreased by -12.48% in the past year. This is quite bad
The Revenue has been growing by 39.74% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-149.44%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-166.79%
Revenue 1Y (TTM)-12.48%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-27.43%

3.2 Future

SCANA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.20% yearly.
The Revenue is expected to decrease by -1.05% on average over the next years.
EPS Next Y-118.84%
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%
EPS Next 5YN/A
Revenue Next Year-16.87%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.72, the valuation of SCANA can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of SCANA indicates a rather cheap valuation: SCANA is cheaper than 88.78% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.13, SCANA is valued rather cheaply.
With a Price/Forward Earnings ratio of 15.11, SCANA is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as SCANA.
The average S&P500 Price/Forward Earnings ratio is at 22.35. SCANA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 9.73
Fwd PE 15.11
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SCANA is valued a bit more expensive than 63.55% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SCANA indicates a rather cheap valuation: SCANA is cheaper than 80.37% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.29
EV/EBITDA 14.86
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as SCANA's earnings are expected to decrease with -4.20% in the coming years.
PEG (NY)N/A
PEG (5Y)0.46
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%

0

5. Dividend

5.1 Amount

SCANA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SCANA ASA

OSL:SCANA (11/5/2025, 7:00:00 PM)

1.556

+0.03 (+2.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners1.24%
Inst Owner ChangeN/A
Ins Owners10.16%
Ins Owner ChangeN/A
Market Cap718.70M
Revenue(TTM)1.65B
Net Income(TTM)-54300000
Analysts86.67
Price Target1.94 (24.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-61.68%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-8.4%
Min Revenue beat(2)-19.55%
Max Revenue beat(2)2.75%
Revenue beat(4)2
Avg Revenue beat(4)-6.93%
Min Revenue beat(4)-19.55%
Max Revenue beat(4)2.75%
Revenue beat(8)4
Avg Revenue beat(8)-0.82%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-115.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.73
Fwd PE 15.11
P/S 0.44
P/FCF 8.29
P/OCF 4.3
P/B 1.18
P/tB 3.16
EV/EBITDA 14.86
EPS(TTM)0.16
EY10.28%
EPS(NY)0.1
Fwd EY6.62%
FCF(TTM)0.19
FCFY12.06%
OCF(TTM)0.36
OCFY23.26%
SpS3.57
BVpS1.32
TBVpS0.49
PEG (NY)N/A
PEG (5Y)0.46
Graham Number2.18
Profitability
Industry RankSector Rank
ROA -3.43%
ROE -8.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.32%
FCFM 5.26%
ROA(3y)2.29%
ROA(5y)7.89%
ROE(3y)5.28%
ROE(5y)21.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y22.03%
OM growth 5Y228.51%
PM growth 3Y-21.04%
PM growth 5Y11%
GM growth 3Y5.71%
GM growth 5Y6.61%
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 6.34
Debt/EBITDA 4.33
Cap/Depr 68.92%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion 196.94%
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.79
Altman-Z N/A
F-Score4
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)42.24%
Cap/Depr(5y)32.52%
Cap/Sales(3y)2.81%
Cap/Sales(5y)1.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-149.44%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%-166.79%
EPS Next Y-118.84%
EPS Next 2Y-20.75%
EPS Next 3Y-4.2%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.48%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%-27.43%
Revenue Next Year-16.87%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.05%
Revenue Next 5YN/A
EBIT growth 1Y-121.24%
EBIT growth 3Y125.68%
EBIT growth 5Y359.05%
EBIT Next Year-10.22%
EBIT Next 3Y16.57%
EBIT Next 5YN/A
FCF growth 1Y-5.56%
FCF growth 3Y41.29%
FCF growth 5Y3.96%
OCF growth 1Y49.17%
OCF growth 3Y80.15%
OCF growth 5Y20.9%

SCANA ASA / SCANA.OL FAQ

What is the fundamental rating for SCANA stock?

ChartMill assigns a fundamental rating of 3 / 10 to SCANA.OL.


What is the valuation status of SCANA ASA (SCANA.OL) stock?

ChartMill assigns a valuation rating of 5 / 10 to SCANA ASA (SCANA.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for SCANA ASA?

SCANA ASA (SCANA.OL) has a profitability rating of 4 / 10.


What is the valuation of SCANA ASA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SCANA ASA (SCANA.OL) is 9.73 and the Price/Book (PB) ratio is 1.18.


How financially healthy is SCANA ASA?

The financial health rating of SCANA ASA (SCANA.OL) is 1 / 10.